← Back to Search

Device

Selective Cytopheretic Device for Heart Failure

N/A

Waitlist Available

Research Sponsored by Lenar Yessayan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 4 weeks following last scd treatment

Awards & highlights

Study Summary

This trial is to test a new device, the SCD, to see if it's safe and if it can reduce damage to the kidney. The SCD is a cartridge used with a commercial hemodialysis unit, and the trial will involve 3 4-hour sessions on hemodialysis.

Eligible Conditions

Heart Failure
Congestive Heart Failure
Kidney Failure
Cardio-Renal Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 4 weeks following last scd treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 4 weeks following last scd treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 weeks following last scd treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Improvement in Cardiac Function - Left Ventricular Ejection Fraction

Secondary outcome measures

Improved renal function as measured by blood urea nitrogen (BUN)

Improved renal function as measured by serum creatinine

Trial Design

1Treatment groups

Experimental Treatment

Group I: Selective Cytopheretic DeviceExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Lenar YessayanLead Sponsor

2 Previous Clinical Trials

20 Total Patients Enrolled

1 Trials studying Heart Failure

10 Patients Enrolled for Heart Failure

Keith Aaronson, MDLead Sponsor

1 Previous Clinical Trials

10 Total Patients Enrolled

1 Trials studying Heart Failure

10 Patients Enrolled for Heart Failure

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is this clinical trial being participated in?

"Affirmative. According to clinicaltrials.gov, this medical investigation is actively enrolling participants after its initial posting on December 1st 2022 and latest update on October 31st 2022. The trial necessitates the recruitment of 10 individuals from one site."

Answered by AI

Do I meet the criteria to be a participant in this experiment?

"Potential participants have to meet two criteria: they must be between 21 and 70 years old, and possess a diagnosed case of heart failure. Unfortunately, the trial is capped at 10 individuals."

Answered by AI

Is this study still accepting participants?

"This medical trial is recruiting as per the information available on clinicaltrials.gov, beginning in December of 2022 and last updated at the end of October that same year."

Answered by AI

Do you accept individuals over the age of fifty-five for this experiment?

"This medical experiment has established a strict age range for eligibility, accepting individuals that are between 21 to 70. Conversely, there is 398 trials available for minors and 1,713 studies reserved for elderly persons."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)

Lenar Yessayan 2024. "SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04589065.